MAPT and Alzheimer disease: Alterations of phosphatidylinositol 3-kinase/AKT (PI3K/AKT) signaling, observed as well in AD, modulate autophagy and contribute to Tau phosphorylation, Aβ toxicity, and neuroinflammation [5,7,8].